Sitalix M

Sitalix-M combines Sitagliptin Phosphate (50 mg) and Metformin Hydrochloride (500 mg) to effectively manage blood sugar levels in adults with type 2 diabetes. Sitagliptin a DPP-4 inhibitor enhances insulin secretion and decreases hepatic glucose production while Metformin improves insulin sensitivity and reduces intestinal glucose absorption. This dual-action formulation supports optimal glycemic control and helps reduce the risk of diabetes-related complications making it an ideal choice for individuals seeking comprehensive diabetes management.